Discover open access scientific publications

Search, annotate, share and cite publications

Publications by F. Komaki

Letter: Immunogenicity of Infliximab Originator vs. CT-P13 in IBD Patients-Authors’ Reply

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Systematic Review With Meta-Analysis: The Efficacy and Safety of CT-P13, a Biosimilar of Anti-Tumour Necrosis Factor-Α Agent (Infliximab), in Inflammatory Bowel Diseases

Alimentary Pharmacology and Therapeutics

Gastroenterology

English